TherapeuticsMD, Inc. (TXMD)
NASDAQ · Healthcare
TherapeuticsMD, Inc. Shareholder Equity 2011–2025
TherapeuticsMD, Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- TherapeuticsMD, Inc. shareholder equity as of December 31, 2025: 26.9M, a 1.80% decrease year-over-year.
- TherapeuticsMD, Inc. shareholder equity for 2025 were 26.9M, a 1.80% decrease from 2024.
- TherapeuticsMD, Inc. shareholder equity for 2024 were 27.4M, a 6.55% decrease from 2023.
- TherapeuticsMD, Inc. shareholder equity for 2023 were 29.3M, a 16.66% decrease from 2022.
- TherapeuticsMD, Inc. shareholder equity for 2022 were 35.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| TherapeuticsMD, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $27 |
| 2024 | $27 |
| 2023 | $29 |
| 2022 | $35 |
| 2021 | $-94 |
| 2020 | $-124 |
| 2019 | $9 |
| 2018 | $98 |
| 2017 | $130 |
| 2016 | $127 |
| 2015 | $63 |
| 2014 | $48 |
| 2013 | $55 |
| 2012 | $-1 |
| 2011 | $-2 |
TherapeuticsMD, Inc. Shareholder Equity — FAQ
TherapeuticsMD, Inc. (TXMD) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TXMD's shareholder equity history?
The chart and table above show TherapeuticsMD, Inc.'s shareholder equity by year and by quarter, including the growth rate.